← All companiesSSyndax Pharmaceuticals Inc
SNDX - CIK 0001395937
Syndax Pharmaceuticals Inc net income by year
Syndax Pharmaceuticals Inc (SNDX) reported net income of -$285.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
SNDX annual net income
SNDX net income 2014-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$285.40M | +10.5% |
| FY 2024 | -$318.80M | -52.2% |
| FY 2023 | -$209.40M | -40.3% |
| FY 2022 | -$149.30M | -699.6% |
| FY 2021 | $24.90M | +134.0% |
| FY 2020 | -$73.16M | -30.5% |
| FY 2019 | -$56.05M | +24.2% |
| FY 2018 | -$73.96M | -21.6% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Syndax Pharmaceuticals Inc make?
Syndax Pharmaceuticals Inc (SNDX) reported net income of -$285.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Syndax Pharmaceuticals Inc's net income changed over time?
Between fiscal 2014 and fiscal 2025, Syndax Pharmaceuticals Inc's net income declined from -$19.83M to -$285.40M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.